Abstract
Background: Pretest probability assessment by a clinical prediction rule (CPR) is an important step in the management of patients with suspected pulmonary embolism (PE). A limitation to the use of CPRs is that their constitutive variables and corresponding number of points are difficult to memorize. A simplified version of the Geneva score (i.e. attributing one point to each variable) has been proposed but never been prospectively validated.
Aims: Prospective validation of the simplified Geneva score (SGS) and comparison with the previous version of the Geneva score (GS).
Methods: In the ADJUST-PE study, which had the primary aim of validating the age-adjusted D-dimer cut-off, the SGS was prospectively used to determine the pretest probability in a subsample of 1621 study patients.
Results: Overall, PE was confirmed in 294 (18.1%) patients. Using the SGS, 608 (37.5%), 980 (60.5%) and 33 (2%) were classified as having a low, intermediate and high clinical probability. Corresponding prevalences of PE were 9.7%, 22.4% and 45.5%; 490 (30.1%) patients with low or intermediate probability had a D-dimer level below 500gL(-1) and 653 (41.1%) had a negative D-dimer test according to the age-adjusted cut-off. Using the GS, the figures were 491(30.9%) and 650 (40.9%). None of the patients considered as not having PE based on a low or intermediate SGS and negative D-dimer had a recurrent thromboembolic event during the 3-month follow-up.
Conclusions: The use of SGS has similar efficiency and safety to the GS in excluding PE in association with the D-dimer test.
| Original language | English |
|---|---|
| Pages (from-to) | 1764-1769 |
| Number of pages | 6 |
| Journal | Journal of Thrombosis and Haemostasis |
| Volume | 15 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sept-2017 |
Keywords
- age-adjusted D-dimer cut-off
- clinical prediction rules
- diagnosis
- diagnostic tests
- pulmonary embolism
- D-DIMER
- PREDICTION RULES
- DECISION RULES
- MANAGEMENT
- DIAGNOSIS
- EMERGENCY
- MODEL
- METAANALYSIS
- TRIAL